American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow AMWL
American Well Corporation (AMWL) EV/Sales
As of 16 October 2026, American Well Corporation (AMWL) trades at a EV/Sales of 0.0×. Over the past ten years it has ranged from −0.8× (June 2024) to 14.3× (April 2021); the current reading is higher than 48% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −0.4× | — |
| FY2024 | −0.5× | — |
| FY2023 | 0.2× | (81.71%) |
| FY2022 | 0.8× | (72.84%) |
| FY2021 | 3.1× | (47.84%) |
| FY2020 | 6.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | −0.2× | — |
| Mar 2026 | −0.4× | — |
| Dec 2025 | −0.4× | — |
| Sep 2025 | −0.4× | — |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation | 0.0× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| SY So-Young International Inc. Sponsored ADR compare | 0.5× |
| LFMD LifeMD, Inc. compare | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.6× |
| SPOK Spok Holdings, Inc. compare | 1.5× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| CSLT Castlight Health, inc. compare | 1.9× |
| CARL Carlsmed, Inc. compare | 4.6× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)